Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings
Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings. // Archivos de Bronconeumología. – URL: https://www.sciencedirect.com/science/article/pii/S0300289626001493?dgcid=rss_sd_all
Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings. Archivos de Bronconeumología. https://www.sciencedirect.com/science/article/pii/S0300289626001493?dgcid=rss_sd_all
“Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings.” Archivos de Bronconeumología.
@article{article97454,
title = {Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings},
journal = {Archivos de Bronconeumología},
url = {https://www.sciencedirect.com/science/article/pii/S0300289626001493?dgcid=rss_sd_all}
}